Haemodynamic setting of essential hypertension as a guide to management.
D000959:Antihypertensive Agents / Q000494:pharmacology*; D001158:Arteries / Q000503:physiopathology*; D001794:Blood Pressure; D002302:Cardiac Output; D003000:Clonidine / Q000494:pharmacology / Q000627:therapeutic use; D003981:Diazoxide / Q000494:pharmacology / Q000627:therapeutic use; D004232:Diuretics / Q000494:pharmacology / Q000627:therapeutic use; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D006973:Hypertension / Q000150:complications / Q000188:drug therapy / Q000503:physiopathology*; D007263:Infusions, Parenteral; D009203:Myocardial Infarction / Q000150:complications; D011433:Propranolol / Q000494:pharmacology / Q000627:therapeutic use; D012964:Sodium / Q000494:pharmacology; D014655:Vascular Resistance
D000959:Antihypertensive Agents; D004232:Diuretics; D012964:Sodium; D011433:Propranolol; D003000:Clonidine; D003981:Diazoxide